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Abstract 
Streptococcus pneumoniae is a globally important encapsulated human pathogen with 
approximately 100 different serotypes recognized.  Serogroup 23 consists of serotype 23F, 
present in licensed vaccines, and emerging serotypes 23A and 23B.  Here, we report the 
previously unknown structures of the pneumococcal capsular polysaccharides serotype 23A 
and 23B determined using genetic analysis, NMR spectroscopy, composition and linkage 
analysis and Smith degradation (of polysaccharide 23A).  The structure of the serotype 23A 
capsular polysaccharide is: →4)-β-D-Glcp-(1→3)-[[α-L-Rhap-(1→2)]-[Gro-(2→P→3)]-β-D-
Galp-(1→4)]-β-L-Rhap-(1→.  This structure differs from polysaccharide 23F as it features a 
disaccharide backbone and the di-substituted β-Gal is linked to β-Rha as a side chain.  This is 
due to the different polymerization position catalysed by the unusually divergent repeat unit 
polymerase Wzy in the 23A cps biosynthesis locus.  Steric crowding in 23A, confirmed by 
molecular models, causes the NMR signal for H-1 of the di-substituted 2,3-β-Gal to resonate 
in the α- anomeric region.  The structure of the serotype 23B capsular polysaccharide is the 
same as 23F, but without the terminal α-Rha: →4)-β-D-Glcp-(1→4)-[Gro-(2→P→3)]-β-D-
Galp-(1→4)-β-L-Rhap-(1→.  The immunodominant terminal α-Rha of 23F is more sterically 
crowded in 23A and absent in 23B. This may explain the reported typing cross reactions for 
serotype 23F: slight with 23A and none with 23B. 
 
Keywords: Streptococcus pneumoniae, Capsular polysaccharide, Serotype 23A, Serotype 
23B, NMR spectroscopy. 
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1. Introduction 
Streptococcus pneumoniae is a globally important encapsulated human pathogen and 
approximately 100 different serotypes have been recognized [1].  Despite extensive genetic 
and serological studies, the polysaccharide structures of several serotypes have yet to be 
determined.  Serogroup 23 consists of serotypes 23F, 23A and 23 B, of which only the 
structure of polysaccharide 23F has been published [2].  Based on the epidemiology at the 
time, serotype 23F was chosen for inclusion in the 23-valent polysaccharide vaccine [3] and 
23F is currently present in all licensed conjugate vaccines.  Epitope specificity studies on 
synthetic conjugates and killed S. pneumoniae 23F in animals showed that the terminal α-
Rha is immunodominant [4]; this has also been observed in human sera from subjects 
immunized with PPV23 [5].  Early studies showed that typing antiserum prepared in rabbits 
with type 23F bacteria reacts only slightly with serotype 23A and hardly at all with serotype 
23B [3] and therefore cross-protection from the 23F polysaccharide and conjugate vaccines is 
not expected.  It is therefore unsurprising that serotype 23A and 23B have been identified as 
emerging pathogens due to a combination of serotype replacement and antimicrobial 
resistance [6-11].  
 
The genes required for pneumococcal capsular polysaccharide (CPS) synthesis are generally 
encoded on the cps locus [12].  The locus contains three types of enzymes: those responsible 
for (i) biosynthesis of nucleotide-activated sugars, (ii) polysaccharide repeat-unit synthesis 
and (iii) assembly of the repeat units and transport across the membrane.  In 23F, WchA 
initiates the repeat-unit synthesis by catalysing the production of an undecaprenyl 
pyrophosphate (UndPP)-D-Glucose.  In successive steps, WchF adds a L-rhamnose to the 
UndPP-Glucose, followed by WchV linking a D-galactose.  This D-galactose is extended by 
WchW and WchX adding a L-rhamnose and a glycerol-2-phosphate, respectively.  Wzx flips 
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a single repeat unit into the periplasm, where the Wzy polymerase links the D-glucose at 
reducing end of the growing chain to the position 4 of the single repeat units’ D-galactose, 
resulting in the mature polysaccharide [13].  Wzg, Wzh, Wzd, and Wze are involved in the 
modulation of capsule synthesis [14].  Biosynthesis of dTDP-L-rhamnose is achieved via the 
RmlACBD genes, while CDP-2-glycerol biosynthesis requires Gtp123 [15].  The serogroup 
23 cps loci sequences share the same 18 genes with a varying degree of similarity. 
 
The published structure for the 23F polysaccharide was elucidated by use of chemical and 
spectroscopic analysis performed on the native and de-phosphorylated polysaccharide and 
fragments generated by partial hydrolysis and periodate treatment [2].  1H NMR assignments 
were presented for the native and de-phosphorylated polysaccharide, however, the 13C NMR 
spectrum was not assigned.  Here we describe detailed 1D and 2D 1H, 13C and 31P NMR 
experiments performed on the 23F polysaccharide in order to make full NMR assignments 
that were used to facilitate the structural elucidation of the structurally related serotype 23A 
and 23B polysaccharides.  
 
2. Results and discussion 
 
2.1. Genetic analysis and predicted structures for serotype 23A and 23B capsular 
polysaccharide repeating units 
The presence of the same glycosyltransferase (GT) genes (wchA, wchF, wchV, wchW and 
wchX) that are present in the cps locus of serotype 23F, indicates the possibility that serotype 
23A and 23B contain the same monosaccharide composition as serotype 23F (Fig. 1). 
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The cps cluster of serotype 23A is similar to 23F, with the notable exception of the 
oligosaccharide polymerase Wzy.  A comparison of Wzy sequences from all S. pneumoniae 
serotype cps clusters (see Suppl. Fig. S1) reveals that even though 23A Wzy is most closely 
related to Wzy of 23F and 23B, the divergence is as high as what can be observed between 
polymerases belonging to different serogroups.  The specificity of Wzy protein sequence to 
the polysaccharide subunit has been postulated and exploited for serotyping purposes [16].  
Thus it can be hypothesized that the repeating unit of the 23A CPS is identical to the 
repeating unit of 23F CPS, but that the serotype difference occurs due to a different 
polymerization linkage of the single repeating units. 
 
In the cps cluster of serotype 23B, the highest sequence diversity towards other GTs of the 23 
group is observed for WchA and WchW.  The function of WchA is biochemically 
demonstrated as undecaprenyl-phosphate glucosyl-1-phosphate transferase [17] which is a 
highly conserved function irrelevant to sequence diversity within S. pneumoniae [12].  
WchW is a putative α-1,2-L-rhamnosyltransferase [13].  A search for WchW homologues 
revealed no hits outside of serogroup 23 cps loci within S. pneumoniae; however a 
homologue to WchW was found in the cps locus of Klebsiella pneumoniae serotype K56, 
designated as WcpL (accession CZQ24634 [18]).  The K. pneumoniae K56 CPS repeating 
unit also contains a rhamnose which is α-1,2-linked to galactose [19].  The fact that WchW of 
23B has the lowest sequence identity to WchW of 23A/F suggests that there may be a 
different bond between the L-rhamnose and the D-galactose, possibly explaining the 
serotyping differences.  The close homology between the 23B and 23F repeat unit 
polymerases (Wzy), suggests a similar polymerization for both serotypes. 
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2.2. NMR assignments for serotype 23F capsular polysaccharide repeating unit 
Chemical analysis of the 23F polysaccharide gave the expected results.  GC analysis of the 
alditol acetate derivatives confirmed the presence of Rha, Gal and Glc in the molar ratio 1.8 : 
0.9 : 1.0, whereas GC analysis of the chiral glycosides showed that the hexoses were in the D 
absolute configuration and Rha in the L absolute configuration.  The linkage positions for the 
constituent sugars were determined by GC and GC-MS analysis of the partially-methylated 
alditol acetate (PMAA) derivatives (Table 1, columns I and II).  The 23F polysaccharide 
contains terminal Rha (t-Rha), 4-linked Rha (4-Rha), 4-linked Glc (4-Glc) and 2,3,4-linked 
Gal (2,3,4-Gal).  The presence of 2,4-linked Gal (2,4-Gal) is due to loss of the 3-linked 
phosphoglycerol substituent during the longer base treatment required to achieve higher 
levels of methylation.  The low amount of terminal Rha detected was attributed to 
decomposition during the strong acid hydrolysis conditions employed and to the volatile 
nature of trimethylated deoxy sugars. 
 
The 1H NMR spectrum (Fig. 2A) shows the expected signals for the 23F tetrasaccharide 
repeating unit (RU): four H-1, ring signals, sharp peaks from glycerol and two methyl signals 
from α- and β-Rha, together with small signals from residual cell wall polysaccharide 
(CWPS).  The diagnostic anomeric and methyl proton signals were used as starting points for 
the 1H-1H correlation experiments (COSY and TOCSY) which elucidated H-1 to H-6 for β-
Glc, α- and β-Rha and H-1 to H-4 for β-Gal. H-5 of β-Gal was assigned from the H-1/H-5 
crosspeak in the NOESY experiment and H-6 from the H-4/C-6 crosspeak in the HSQC-
NOESY experiment.  All of the HSQC crosspeaks (Fig. 3) could be assigned from the proton 
assignments already established aided by overlays with 1D TOCSY (200 ms), HSQC-
TOCSY, HSQC-NOESY and HMBC experiments.  The 1H and 13C NMR data are collected 
in Table 2.  The deshielded carbons and glycosylation shifts compared to the corresponding 
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monosaccharide [21] confirmed the linkage positions: C-2 (+2.73 ppm), C-3 (+4.45 ppm) and 
C-4 (+4.65 ppm) of β-Gal, C-4 (+4.96 ppm) of β-Rha and C-4 (+6.90 ppm) of β-Glc.  The 
relatively small glycosylation shift for C-2 of Gal has been observed for other 2,3-β-Gal 
residues in serotypes 15B and 33F and was attributed to the strong steric hindrance imposed 
by vicinal 2,3-disubstitution [22].  The sequence of sugar residues indicated by glycosylation 
shifts followed from the HMBC interresidue correlations (Suppl. Fig. S2A) and 
transglycosidic correlations in the NOESY experiment.  The 1H-31P HMBC experiment 
showed major crosspeaks from the phosphodiester signal at -0.09 ppm to H-3 of β-Gal at 4.33 
ppm and H-2 (and H-1/H-3) of Gro confirming the presence of the Gro-(2→P→3)-β-D-Galp-
linkage.  An expansion of the fully assigned 13C NMR spectrum is shown in Fig. 4A; the 
splitting of C-2 of glycerol (6 Hz) is from 31P coupling.  Lastly the proton-coupled 13C 
spectrum gave JH1,C1 for the anomeric carbons confirming the α- configuration of the terminal 
Rha (174 Hz) and β- for the remaining residues (162-168 Hz).  Thus NMR analysis 
confirmed the structure of the tetrasaccharide repeating unit of serotype 23F polysaccharide 
as →4)-β-D-Glcp-(1→4)-[α-L-Rhap-(1→2)]-[Gro-(2→P→3)]-β-D-Galp-(1→4)-β-L-Rhap-
(1→.  
 
2.3. Structure of serotype 23A capsular polysaccharide repeating unit 
Composition analysis of the 23A polysaccharide gave similar results to those obtained for 
23F.  GC analysis of the alditol acetate derivatives showed the presence of Rha, Gal and Glc 
in the molar ratio 2.3 : 0.7 : 1.0.  This was confirmed by GC-MS analysis of the TMS methyl 
glycosides (Suppl. Fig. S3A) which also gave poor release of Gal (relative peak areas of 0.45 
: 0.20 : 1.00).  A small amount of glycerol was also detected by MS.  GC analysis of the 
chiral glycosides showed that the hexoses were in the D absolute configuration and Rha in the 
L absolute configuration as for 23F.  The linkage positions for the constituent sugars were 
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determined by GC and GC-MS analysis of the PMAA derivatives (Table 1, columns III and 
IV).  In contrast to the 23F polysaccharide, the 23A polysaccharide contains terminal Rha (t-
Rha), 4-linked Glc (4-Glc) and 2,3-linked Gal (2,3-Gal) instead of 2,3,4-Gal.  The low 
amounts of 2-linked Gal (2-Gal) are due to some loss of the 3-linked phosphoglycerol 
substituent during the potassium dimsyl base treatment.  Base treatment for 2 h resulted in 
higher levels of methylation (Table 1, column IV) and showed the presence of 3,4-linked Rha 
(3,4-Rha) not detectable in the first methylation analysis.  The linkage analysis showing the 
presence of 2,3-Gal and the doubly-branched Rha was confirmed by NMR analysis. 
 
The 1H NMR spectrum (Fig. 2B) shows signals for the 23A tetrasaccharide RU: four H-1, 
ring signals, sharp peaks from glycerol and two methyl signals from α- and β-Rha, together 
with small signals from residual CWPS.  Similar chemical shifts and coupling constants were 
observed for α- and β-Rha and β-Glc compared to the spectrum of 23F (Fig. 2A).  The major 
difference is the presence of a new H-1 signal at 5.17 ppm attributed to Gal.  This chemical 
shift is in the α- anomeric region, however, the large coupling with H-2 (7.8 Hz) is 
characteristic of β-Gal [23].  A full set of 1H, 13C and 31P 1D and 2D NMR experiments were 
performed, as described for the 23F polysaccharide.  As for 23F, the COSY and TOCSY 
experiments elucidated H-1 to H-4 for Gal and H-5 was assigned from the H-1/H-5 crosspeak 
in the NOESY experiment; this constitutes further proof of the β- configuration for Gal.  As 
for 23F, all of the HSQC crosspeaks (Fig. 5) could be assigned from the proton assignments 
aided by appropriate overlays with hybrid and HMBC experiments.  The 1H and 13C NMR 
data are collected in Table 3.  The deshielded carbons and glycosylation shifts established the 
linkage positions: C-2 (+2.83 ppm) and C-3 (+4.85 ppm) of β-Gal, C-3 (+9.47 ppm) and C-4 
(+1.10 ppm) of β-Rha and C-4 (+6.50 ppm) of β-Glc.  The small glycosylation shift for C-4 
of β-Rha has been observed for 3,4-β-Rha in serotype 17F [24]; this can be attributed to the 
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strong steric hindrance imposed by vicinal disubstitution.  The sequence of sugar residues 
indicated by glycosylation shifts followed from the HMBC interresidue correlations (Suppl. 
Fig. S2B) and transglycosidic correlations in the NOESY experiment.  The 1H-31P HMBC 
experiment showed major crosspeaks from the phosphodiester signal at -0.68 ppm to H-3 of 
β-Gal at 4.25 ppm and H-2 (and H-1/H-3) of Gro confirming the presence of the Gro-
(2→P→3)-β-D-Galp-linkage.  An expansion of the fully assigned 13C NMR spectrum is 
shown in Fig. 4B; the splitting of C-2 of glycerol (6 Hz) is from 31P coupling.  Lastly the 
proton-coupled 13C spectrum gave JH1,C1 for the anomeric carbons confirming the α- 
configuration of the terminal Rha (173 Hz) and β- for the remaining residues (162-168 Hz) 
including the Gal (168 Hz).  Thus NMR analysis established the structure of the 
tetrasaccharide repeating unit of serotype 23A polysaccharide as →4)-β-D-Glcp-(1→3)-[[α-
L-Rhap-(1→2)]-[Gro-(2→P→3)]-β-D-Galp-(1→4)]-β-L-Rhap-(1→. The repeating unit 
structure and anomeric configuration of Gal was confirmed by Smith degradation studies 
which yielded a major oligosaccharide product 23ASD.  
 
Periodate oxidation of the proposed repeating unit structure would be expected to 
depolymerize the polysaccharide by oxidation of the 4-linked β-Glc in the sugar backbone 
and to oxidize the terminal α-Rha on the 2,3-linked Gal side chain to yield an oligosaccharide 
product that would be amenable to analysis.  1H NMR analysis of the major Smith 
degradation product, 23ASD, showed the presence of β-Rha (H-1 at 4.77 and H-6 at 1.37 
ppm) and H-1 of β-Gal at 4.64 ppm, the expected chemical shift region for a β-linked Gal 
(Figure 6).  
 
Full NMR characterization of 23ASD elucidated the oligosaccharide as β-D-Galp-(1→4)-β-
L-Rhap-(1→2)-threitol; the labelled HSQC spectrum and chemical shift data are presented in 
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Suppl. Fig. S4 and Table 3 (lower panel), respectively.  The threitol is derived from oxidation 
followed by borohydride reduction of the 4-linked Glc and β-Gal is terminal due to oxidation 
and cleavage of the α-Rha linked to C-2 and loss of the 3-linked phosphoglycerol substituent 
during NaBH4 treatment.  The disaccharide chemical shift data are in good agreement with 
those predicted by CASPER [25].  These results unambiguously prove that the 2,3-linked Gal 
residue in serotype 23A has the β- configuration.  H-1 of 2,3,4-β-Gal linked to C-4 of Rha in 
serotype 23F resonates at 4.95 ppm, however, it is strongly deshielded to 5.17 ppm in the 
23A polysaccharide which has the 2,3-β-Gal linked to C-4 of the 3,4-disubstituted Rha.  
 
2.4. Structure of serotype 23B capsular polysaccharide repeating unit 
Composition analysis of the 23B polysaccharide gave similar results to those obtained for 
23F and 23A.  GC-MS analysis of the TMS methyl glycosides (Fig. S2B) showed the 
presence of Rha, Gal and Glc (relative peak areas of 0.22 : 0.53 : 1.00) together with trace 
amounts of glycerol.  The 1H NMR spectrum (Fig. 2C) shows signals for the 23B 
trisaccharide RU: three H-1, ring signals, sharp signals from glycerol and one methyl signal 
from β-Rha, together with signals from residual CWPS.  The 1D spectrum indicated that 23B 
has the same structure as 23F, but without the terminal α-Rha. This was confirmed by the full 
set of 1H, 13C and 31P 1D and 2D NMR experiments performed.  All of the HSQC crosspeaks 
(Fig. 7) could be assigned from the proton assignments aided by appropriate overlays with 
hybrid and HMBC experiments.  The 1H and 13C NMR data are collected in Table 4.  The 
deshielded carbons and glycosylation shifts established the linkage positions: C-3 (+4.15 
ppm) and C-4 (+4.38 ppm) of β-Gal, C-4 (+8.96 ppm) of β-Rha and C-4 (+7.10 ppm) of β-
Glc.  The similarity of the glycosylation shifts to those obtained for 23F provide proof that 
the bonds have the same configuration factors i.e. that the hexoses have the D absolute 
configuration and Rha the L absolute configuration.  The sequence of sugar residues indicated 
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by glycosylation shifts followed from the HMBC interresidue correlations (Suppl. Fig. S2C) 
and transglycosidic correlations in the NOESY experiment.  The 1H-31P HMBC experiment 
showed major crosspeaks from the phosphodiester signal at -0.26 ppm to H-3 of β-Gal at 4.26 
ppm and H-2 (and H-1/H-3) of Gro confirming the presence of the Gro-(2→P→3)-β-D-Galp-
linkage.  An expansion of the fully assigned 13C NMR spectrum is shown in Fig. 4C; the 
splitting of C-2 of glycerol (5.8 Hz) is from 31P coupling.  Lastly the proton-coupled 13C 
spectrum gave JH1,C1 for the anomeric carbons confirming the β-configuration for all the 
residues (162-165 Hz).  Thus NMR analysis established the tetrasaccharide repeating unit of 
serotype 23B polysaccharide as →4)-β-D-Glcp-(1→4)-[Gro-(2→P→3)]-β-D-Galp-(1→4)-β-
L-Rhap-(1→.  
 
2.5 Molecular models 
Molecular models of 10RU of the three polysaccharides were built with CarbBuilder [26] and 
subsequently minimized.  The models for 23F and 23B show the same loose helical 
conformation (Fig. 8), with a helical pitch of approximately 40 Å and 15 residues per helical 
turn.  However, the immunodominant terminal α-Rha in 23F (absent in 23B) is clearly 
exposed on the edge of the helix (purple residues in Fig. 8), and would present a markedly 
different surface for antibody binding than 23B.  In contrast to the conformations of 23F and 
23B, the model for 23A is not a helix at all, but a slightly twisted flat ribbon, with clear steric 
crowding at the β-L-Rha branch point: the β-Glc is in close proximity to β-Gal (< 3 Å).  This 
model thus explains the strong deshielding of H-1 of 2,3-β-Gal observed in the NMR 
spectrum of polysaccharide 23A.  Further, the presentation of the terminal α-Rha in 23A is 
quite different to 23F: the α-Rha forms a long, almost straight line along the chain in 23A, as 
opposed to its orientation in the 23F helix.  The different conformations depicted in these 
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preliminary models suggest little likelihood of cross-protection between either 23F or 23B 
with 23A.  
 
3. Conclusions 
Structural predictions of the 23A and 23B polysaccharide based on the genetic analyses are in 
agreement with the experimentally-obtained structures.  The biological repeat units of the two 
polysaccharides can be identified with confidence, and the glycosyltransferases responsible 
for each elongation step can be assigned by comparison with the 23F cps locus (Fig. 9). 
 
The low similarity between the polymerase Wzy of the 23A and 23F cps locus is reflected in 
the different polymerization which results in a significantly divergent polysaccharide 
structure, where the backbone is constituted by the repetition of the →3)-β-L-Rhap-(1→4)-β-
D-Glcp-(1→ disaccharide.  This is the first report describing a polymerization position on the 
second sugar from the reducing end of the repeat unit in Streptococcus pneumoniae. 
 
WchW activity in 23B is not only different to its 23F counterpart as predicted, but it is even 
absent.  The lack of the α-1-2-linked-rhamnose constitutes the only difference between 23F 
and 23B capsular polysaccharides.  The reasons for WchW’s missing activity are not clearly 
deducible from a comparison of the known homologues; it could be due to either several 
inactivating mutations in the protein, comparing to 23F, or a halt at the transcriptional level.  
As Geno at al. [27] have recently shown, a subtle difference of only two amino acid 
substitutions can be responsible for the inactivation of the acetyltransferase in an isolate of 
serotype 35B, resulting in a novel, non-acetylated serotype.  
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Molecular modelling shows similar helical structures for 23F and 23B, but a markedly 
different sterically-crowded ribbon-like structure for 23A.  The repeating unit structures for 
23A and 23B may explain why the typing antiserum prepared in rabbits with type 23F 
bacteria reacts only slightly with serotype 23A and hardly at all with serotype 23B [3].  In 
23A, the immunodominant terminal α-Rha [5] is no longer a pendant group at C-2 of the 
main backbone 2,3,4-Gal as in 23F, but on C-2 of the sterically constrained 2,3-Gal, now 
present as a side chain (Fig. 8).  This means that the terminal α-Rha of 23A will be less 
accessible to 23F antibody directed against this dominant epitope.  The terminal α-Rha is 
absent in 23B, which results in little or no cross reaction with 23F antisera as reported. 
 
4. Experimental 
Purified pneumococcal polysaccharide serotypes 23A and 23B were purchased from Statens 
Serum Institut (SSI).  A second sample of polysaccharide 23A and the comparator 
polysaccharide 23F were obtained from GlaxoSmithKline Biologicals (Rixensart, Belgium).  
 
4.1. Genetic analysis of serogroup 23 cps locus sequence 
The published cps locus sequences (serotype 23a: accession CR931683; 23b: CR931684; 23f: 
CR931685) and Wzy sequences [12] have been downloaded from GenBank 
(https://www.ncbi.nlm.nih.gov/nuccore).  Pairwise protein sequence identity has been 
assessed using BLASTp [28].  Multiple sequence alignments have been performed using T-
Coffee and standard parameters (v11.00) [29].  Wzy phylogeny was inferred from multiple 
sequence alignments by running RAxML using a gamma distribution to model site-specific 
rate variation and 100 bootstrap replicates [30]. 
 
4.2. Monosaccharide composition analysis by GC and GC-MS 
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Hydrolysis of polysaccharide 23F and 23A samples (0.5 mg) was performed with 2M TFA 
for 2 h at 125 °C and alditol acetates prepared as previously described [31].  GC analysis was 
performed on a Perkin–Elmer Autosystem XL gas chromatograph equipped with a flame 
ionisation detector and SP2330 column (30 m); temperature program: 200 °C for 1 min, 200 
– 245 °C at 4 °C/min, and 245 °C for 16 min.  A mixture of standard monosaccharides (with 
inositol as an internal standard) was used to determine the retention times and response 
factors for each sugar.  
Methanolysis (3 M HCl) of polysaccharide 23F, 23A and 23B samples (0.5 – 1 mg) was 
performed in a CEM Discover SP-d Microwave reactor at 120 W and 121 °C for 5 minutes 
and the tri-methyl silyl ether (TMS) derivatives prepared as described by Kim et al. [32].  
GC-MS analysis was performed on an Agilent 8720A Gas Chromatograph equipped with a 
Agilent 5975 mass spectrometer and a DB-1MS column (30 m); temperature program: 50 °C 
for 2 min, 50 - 150 °C at 30 °C/min,  150 - 220 °C at 3 °C/min, 220 - 300 °C at 30 °C/min 
and 300 °C for 10 min.  The inlet temperature was set at 250 °C and the MS transfer line at 
300 °C.  The MS acquisition parameters were set to scan at m/z 50-550 in electron impact 
(EI) mode.  GC-MS data was processed using Agilent Chemstation software.  A mixture of 
standard monosaccharides was used to determine the retention times and corresponding mass 
spectra for each sugar derivative. 
 
4.3. Monosaccharide absolute configuration analysis by GC and GC-MS 
Determination of the absolute configuration of the monosaccharide residues in 23F and 23A 
was performed according to Gerwig et al. [33].  Poor recovery using the standard method was 
addressed by additional steps of sample preparation.  The samples were sonicated using a 
Branson sonicator equipped with a microtip at 2.8 Å (3X for 60 sec at power 4 in ice, at 1 
min intervals).  Prior hydrolysis of sonicated polysaccharide 23F and 23A samples (0.5 mg) 
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was performed (2M TFA for 2 h at 125 °C) was followed by butanolysis (1 M HCl) in S-(+)-
2-butanol for 16 h at 80 °C and TMS derivatization.  GC analysis was performed on an 
Agilent Technologies 6850 gas chromatograph equipped with a flame ionisation detector and 
an HP-1 column (30 m); temperature program: 50 °C for 1 min, 50 – 130 °C at 45 °C/min, 
130 °C for 1 min, 130 – 200 °C at 1°C/min, and 200 °C for 10 min.  GC–MS (e.i.) analyses 
were carried out on an Agilent Technologies 7890A gas chromatograph coupled to an Agilent 
Technologies 5975C VL MSD, using an HP-1 column (30 m) and the same temperature 
program.  TMS derivatives of monosaccharide standards (all with the D configuration, except 
L-Rha) were prepared using butanolysis (1 M HCl) in S-(+)-2-butanol or R-(-)-2-butanol.  
Attribution to the D- or L- absolute configuration was achieved by comparing the elution time 
of the samples with those of the monosaccharide standards.  GC-MS was used to confirm the 
data obtained with GC and to identify all peaks present in the chromatograms. 
 
4.4. Linkage analysis by methylation and GC-MS 
Permethylation of polysaccharide 23F and 23A samples (0.5 mg), hydrolysis and 
derivatization to partially methylated alditol acetates (PMAA) was achieved following the 
methods described by Harris et al. [34] and Albersheim et al. [31], respectively.  Poor 
recovery using these standard methods was addressed by additional steps: prior sonication of 
the polysaccharides as described in section 2.2, initial addition of a small amount of 
potassium dimsyl and CH3I, in order to achieve some methylation of hydroxyl functions 
which aids solubilization, and by repeating the methylation step with potassium dimsyl and 
CH3I for 30 min instead of 10 min.  A second set of methylation experiments were performed 
using an even longer incubation time of 2 h. PMAA derivatives were analyzed by GC and 
GC-MS.  Identification of the sugar type followed from retention times and the ring size and 
the linkage positions of the glycosidic bonds from the corresponding mass spectra.  
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Quantification of each sugar derivative was achieved by correcting the corresponding area of 
the gas chromatogram by an effective carbon response factor according to Sweet et al. [20].  
GC analysis was performed on a Perkin–Elmer Autosystem XL gas chromatograph equipped 
with a flame ionisation detector and an HP-1 column (30 m); temperature program: 125 °C 
for 1 min, 125 – 240 °C at 4 °C/min, and 240 °C for 2 min.  GC–MS (e.i.) analyses were 
carried out on an Agilent Technologies 7890A gas chromatograph coupled to an Agilent 
Technologies 5975C VL MSD, using an HP-1 column (30 m) and the same temperature 
program. 
 
4.5. Smith degradation of polysaccharide 23A 
Polysaccharide 23A (23 mg) was subjected to complete oxidation with 0.18 mmol of NaIO4 
at 10 °C for 6 days in the dark [35,36].  The reaction was stopped by the addition of glycerol 
and the products were reduced with NaBH4.  Addition of 50% CH3COOH after 16 h 
destroyed the excess of reducing reagent, the sample was dialysed and the product recovered 
by lyophilisation.  Mild hydrolysis (0.5 M TFA) was conducted at room temperature for 6 
days.  The solution was taken to dryness under reduced pressure, dissolved in water, its pH 
adjusted to neutrality, and the product recovered under reduced pressure.  It was then 
separated on a Bio Gel P2 column (1.6 cm i.d. x 90 cm) equilibrated in 50 mM NaNO3 which 
was also used as eluent.  The flow rate was 6 mL/h and fractions were collected at 15 min 
intervals.  Elution was monitored using a refractive index detector (WGE Dr. Bures, 
LabService Analitica) which was connected to a paper recorder and interfaced with a 
computer via picolog software.  One major oligosaccharide, named 23ASD, was obtained 
from the chromatographic separation and purified by dialysis (Float-A-Lyzer, MWCO 100-
500 Da) and treatment with MTO-Dowex marathon (H+, OH-) resin to remove residual salt.  
The 23ASD oligosaccharide was fully characterized by NMR spectroscopy. 
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4.6. NMR spectroscopy 
Polysaccharide samples (~10 mg) were lyophilized and exchanged twice with 99.9 % 
deuterium oxide (Sigma Aldrich), then dissolved in 600 µL of D2O and introduced into a 5 
mm NMR tube for data acquisition.  Preliminary NMR studies yielded broad lines and poor 
2D crosspeaks for polysaccharide 23A and 23F, the spectral resolution was improved by 
placing the NMR sample in a Branson 1200 Sonicator water bath for 1-2 days.  1D 1H, 13C 
and 31P and 2D, COSY, TOCSY, NOESY, HSQC, HMBC and hybrid H2BC, HSQC-
TOCSY and HSQC-NOESY NMR spectra were obtained using a Bruker Advance III 600 
MHz NMR spectrometer equipped with a BBO Prodigy cryoprobe and processed using 
standard Bruker software (Topspin 3.2).  The probe temperature was set at 313 or 323 K.  2D 
TOCSY experiments were performed using mixing times of 120 or 180 ms and the 1D 
variants using mixing times up to 200 ms.  The HSQC experiment was optimized for J = 145 
Hz (for directly attached 1H-13C correlations), and the HMBC experiment optimized for a 
coupling constant of 6 Hz (for long-range 1H-13C correlations).  HSQC-TOCSY and HSQC-
NOESY NMR spectra were recorded using mixing times of 120 and 250 ms respectively.  
Polysaccharide spectra were referenced to residual cell wall polysaccharide signals 
(phosphocholine 1H signal at 3.23 ppm and 13C signal at 54.5 ppm and the shielded 31P signal 
at 1.30 ppm) [37].  Spectra recorded for oligosaccharide 23ASD were referenced relative to 
H6/C6 of β-Rha: 1H at 1.37 ppm, 13C at 17.5 ppm. 
 
4.7. Molecular modeling 
Optimal dihedral angle conformations for the glycosidic linkages were taken from the 
corresponding disaccharide potential of mean force free energy surfaces calculated with the 
metadynamics routine incorporated into NAMD [38], with the φ,ψ glycosidic linkage torsion 
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angles used as collective variables. The optimal conformations are listed in Table 5.  
Molecular models of 10 repeat units of 23F, 23A and 23B were built with CarbBuilder 
version 2.1.17 [26] using the dihedral angles listed in Table 5.  We added bond, angle and 
dihedral parameters to the CHARMM36 additive force field for carbohydrates [39,40] to 
represent the 2-phosphate substitution on glycerol, as well as the glycosidic phosphodiester 
(2->3) linkage.  These parameters were adapted from the ribitol phosphodiester parameters 
previously added to the force field [41].  These initial oligosaccharide structures were 
optimized through 20000 steps of standard NAMD (version 2.9) minimization in vacuum 
[42]. 
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Table 1  
Determination of the glycosidic linkages in pneumococcal polysaccharides 23F and 23A by 
GC-MS of PMAA derivatives. 
 
Linkagea  Relative molar ratioc 
 RRTb Id IIe IIIf IVg 
t-Rha 0.60 0.48 0.14 0.20 0.15 
4-Rha 0.75 0.61 0.64   
3,4-Rha 0.87   n.d. h 0.94 
4-Glc 1.00 1.00 1.00 1.00 1.00 
2-Gal 1.01   0.13 0.11 
2,3-Gal 1.13   0.50 0.59 
2,4-Gal 1.13 0.21 0.22   
2,3,4-Gal 1.21 0.29 0.41   
 
a
 the numbers indicate the position of the glycosidic linkages, e.g. t-Rha= terminal non-
reducing rhamnose; b Relative retention time; c Peak areas were corrected by the effective 
carbon response factor (Sweet et al., 1975,[20]) and the molar ratio are expressed relative to 
4-Glc (set as 1.00); d I = Pn23F polysaccharide methylated for 30 min; e II = Pn23F 
polysaccharide methylated for 2 h; f III = Pn23A polysaccharide methylated for 30 min; g IV 
= Pn23A polysaccharide methylated for 2 h; h n.d. = not detected. 
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Table 2 
1
H and 
13
C NMR chemical shifts (δ, ppm) for the serotype 23F polysaccharide repeating unit 
 
 
Residue 
H-1 
C-1 
H-2 
C-2 
H-3 
C-3 
H-4 
C-4 
H-5 
C-5 
H-6 
C-6 
α-L-Rhap-(1→ 
α-R 
 
5.10 4.15 3.82 3.47 4.10 1.27 
101.66 
 
70.30 
 
70.51 
 
72.37 
 
69.20 
 
16.94 
 
→2,3,4)-β-D-Galp-(1→ 
GA 
 
4.95 3.82 4.33 4.42 3.81 3.94 
101.22 
 
75.69 
 
78.23 
 
74.34 
 
74.45 
 
61.08 
 
→ 4)-β-L-Rhap-(1→ 
β-R 
 
4.86 4.04 3.80 3.70 3.44 1.36 
101.05 71.55 73.91 77.79 71.41 
17.59 
 
→4)-β-D-Glcp-(1→ 
G 
 
4.83 3.36 3.68 3.64 3.53 3.94, 3.83 
102.76 
 
73.81 
 
75.88 
 
77.61 
 
74.78 
 
61.42 
 
Phosphoglycerol at O-3 of Gal: 1H, 13C and 31P assignments; δ CH: 4.29, 77.49; δ CH2: 3.77, 
62.03 and 31P at -0.09 ppm.  
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Table 3 
1
H and 
13
C NMR chemical shifts (δ, ppm) for the serotype 23A polysaccharide repeating unit 
(upper panel) and for the Smith degradation product 23ASD (lower panel) 
 
 
Residue 
H-1 
C-1 
H-2 
C-2 
H-3 
C-3 
H-4 
C-4 
H-5 
C-5 
H-6 
C-6 
α-L-Rhap-(1→ 
α-R 
 
5.06 4.13 3.82 3.49 4.07 1.27 
101.50 
 
70.28 
 
70.85 
 
72.36 
 
69.06 
 
16.93 
 
→2,3)-β-D-Galp-(1→ 
GA 
 
5.17 3.67 4.25 4.18 3.66 ~3.81 
99.53 
 
75.79 
 
78.63 
 
68.51 
 
74.89 
 
61.31 
 
→3,4)-β-L-Rhap-(1→ 
β-R 
 
4.91 4.32 3.95 3.94 3.45 1.37 
100.83 
 
71.37 
 
83.23 
 
73.93 
 
71.45 
 
17.51 
 
→4)-β-D-Glcp-(1→ 
G 
 
4.67 3.40 3.66 3.65 3.54 3.91, 3.85 
104.00 
 
73.69 
 
76.03 
 
77.21 
 
74.95 
 
61.15 
 
β-D-Galp-(1→ 
GA 
 
4.64 3.53 3.65 3.91 3.67 ∼3.77 
104.4 
 
72.4 
 
73.5 
 
69.3 
 
75.8 
 
61.5 
 
→4)-β-L-Rhap-(1→ 
β-R 
4.77 4.04 3.82 3.63 3.48 1.37 
99.8 71.5 73.4 81.6 71.4 17.5 
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Residue 
H-1 
C-1 
H-2 
C-2 
H-3 
C-3 
H-4 
C-4 
H-5 
C-5 
H-6 
C-6 
 
      
→2)-Threitol 
T 
 
3.72, 3.82 3.83 3.83 3.68, 3.73   
61.2 
 
80.6 
 
71.6 
 
63.3 
 
 
 
 
 
Phosphoglycerol at O-3 of Gal: 1H, 13C and 31P assignments; δ CH: 4.27, 77.51; δ CH2: 3.77, 
61.96 and 31P at -0.68 ppm. 
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Table 4 
1
H and 
13
C NMR chemical shifts (δ, ppm) for the serotype 23B polysaccharide repeating unit 
 
 
Residue 
H-1 
C-1 
H-2 
C-2 
H-3 
C-3 
H-4 
C-4 
H-5 
C-5 
H-6 
C-6 
→3,4)-β-D-Galp-(1→ 
GA 
 
4.77 3.80 4.26 4.39 3.73 3.82, 3.76 
104.10 
 
71.34 
 
77.93 
 
74.07 
 
74.77 
 
60.92 
 
→ 4)-β-L-Rhap-(1→ 
β-R 
 
4.86 4.09 3.82 3.63 3.49 1.37 
101.02 
 
71.02 
 
73.27 
 
81.79 
 
71.12 
 
17.35 
 
→4)-β-D-Glcp-(1→ 
G 
 
4.81 3.34 3.68 3.64 3.53 3.94, 3.82 
102.76 
 
73.87 
 
75.91 
 
77.69 
 
74.79 
 
61.43 
 
Phosphoglycerol at O-3 of Gal: 1H, 13C and 31P assignments; δ CH: 4.29, 77.69; δ CH2: 3.76, 
61.9; 31P at -0.26 ppm. 
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Table 5 
Optimal values for the φ,ψ glycosidic linkage torsion angles determined from vacuum 
metadyamics.  
 
Disaccharide φ, ψ 
α-L-Rhap-(1→2)-β-D-Galp 39, 21 
β-D-Glcp-(1→3)-β-L-Rhap 46, 11; 59 -13a 
β-D-Galp-(1→4)-β-L-Rhap 26, 26 
β-D-Glcp-(1→4)-β-D-Galp 44,16 
β-L-Rhap-(1→4)-β-D-Glcp -51, -8 
a Value used for 23A, to avoid atomic collisions. This value is still within the vacuum global 
minimum energy well 
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List of Figures 
Figure 1: Comparison of serogroup 23 cps loci. The results of a pairwise BLASTp protein 
sequence comparison are shown. 
Figure 2: 1D 1H NMR spectra of pneumococcal serotype (A) 23F, (B) 23A and (C) 23B 
capsular polysaccharides. Some signals including the diagnostic anomeric and methyl protons 
are labeled.  
Figure 3: Expansion of the HSQC spectrum of polysaccharide 23F recorded at 600 MHz, the 
crosspeaks from the methyl region of the spectrum are shown in the insert. Key 
tetrasaccharide repeating unit proton/carbon crosspeaks have been labeled according to the 
carbon atom of the corresponding residue (α- and β-R = α- and β-Rha, G = Glc, GA = Gal 
and Gro = glycerol). 
Figure 4: Expansion of the 1D 13C NMR spectra of pneumococcal serotype (A) 23F, (B) 23A 
and (C) 23B capsular polysaccharides showing the anomeric and ring regions. Carbon peaks 
have been labeled according to the corresponding residue (α- and β-R = α- and β-Rha, G = 
Glc, GA = Gal and Gro = glycerol). 
Figure 5: Expansion of the HSQC spectrum of polysaccharide 23A recorded at 600 MHz, the 
crosspeaks from the methyl region of the spectrum are shown in the insert. Key 
tetrasaccharide repeating unit proton/carbon crosspeaks have been labeled according to the 
carbon atom of the corresponding residue (α- and β-R = α- and β-Rha, G = Glc, GA = Gal 
and Gro = glycerol). 
Figure 6: 1D 1H NMR spectra of pneumococcal serotype (A) 23A polysaccharide and (B) 
23ASD, the oligosaccharide obtained after Smith degradation. Some signals including the 
diagnostic anomeric and methyl protons are labeled.  
Figure 7: Expansion of the HSQC spectrum of polysaccharide 23B recorded at 600 MHz, the 
crosspeaks from the methyl region of the spectrum are shown in the insert. Key trisaccharide 
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repeating unit proton/carbon crosspeaks have been labeled according to the carbon atom of 
the corresponding residue β-R = β-Rha, G = Glc, GA = Gal and Gro = glycerol). 
Figure 8: Minimized molecular models for 10RU of 23F (left) 23A (middle) and 23B (right), 
shown in space-filling representation and colored according to residue type.  The models for 
23F and 23B show a similar loose helical conformation, the model for 23A is a slightly 
twisted flat ribbon, with clear steric crowding at the β-L-Rha branch point.  
Figure 9: Proposed glycosyltransferase and polymerase activity in serogroup 23 
polysaccharides.  Glycosyltransferases responsible for each elongation step are listed above 
the respective glycosidic linkage in italics.  The polymerization site is marked by an arrow. 
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Highlights 
• Serotype 23A and 23B subunit structures were predicted from genome sequence 
analysis 
• The structures of the 23A and 23B polysaccharides were elucidated 
• The 23A polysaccharide has a disaccharide backbone and disubstituted 2,3-β-Gal as a 
side chain 
• The 23B polysaccharide is the same as 23F but without the terminal α-Rha 
 
 
